Emerging beneficial roles of sirtuins in heart failure

Basic Research in Cardiology

Volumn 107, Issue 4, 2012, Pages

  Tanno, Masaya ^a   Kuno, Atsushi ^a   Horio, Yoshiyuki ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Heart failure; Metabolism; Mitochondria; Oxidative stress; SIRT1; SIRT3

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CALCIUM ION; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE II; CYCLOPHILIN D; DICHLOROACETIC ACID; ETOMOXIR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 1; MANGANESE SUPEROXIDE DISMUTASE; PERHEXILINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; RESVERATROL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SIRTUIN; SIRTUIN 1; SIRTUIN 3; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; CALCIUM; CARDIOVASCULAR AGENT;

ANGIOGENESIS; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL DEATH; CELL SURVIVAL; CELLULAR DISTRIBUTION; CITRIC ACID CYCLE; CONGESTIVE CARDIOMYOPATHY; ENERGY METABOLISM; EXCITATION CONTRACTION COUPLING; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLYCOLYSIS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HUMAN; INSULIN SENSITIVITY; ISCHEMIC CARDIOMYOPATHY; MITOCHONDRIAL GENE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TARGETING SIGNAL; NONHUMAN; OXIDATIVE STRESS; REVIEW; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE; ANIMAL; ENZYMOLOGY; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CALCIUM; CARDIOVASCULAR AGENTS; CELL DEATH; ENERGY METABOLISM; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIRTUIN 1; SIRTUIN 3;

EID: 84861338375     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0273-5     Document Type: Review

References (129)

1. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 105:14447-14452. doi:10.1073/pnas.0803 790105
2. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100:1512-1521. doi:10.1161/01.RES.0000267723. 65696.4a
3. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J (2004) Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95:971-980. doi:10.1161/01.RES.0000147557.75257.ff
4. An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489-H1506. doi:10.1152/ajpheart. 00278.2006
5. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR (2010) Peroxisome proliferator-activated receptor gamma co-activator 1a (PGC-1a) and sirtuin 1 (SIRT1) reside in mitochondria: Possible direct function in mitochondrial biogenesis. J Biol Chem 285:21590-21599. doi:10.1074/jbc.M109. 070169
6. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M (1993) Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72:463-469
7. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM (2006) Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1a. Proc Natl Acad Sci USA 103:10086-10091. doi:10.1073/ pnas.0603615103
8. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M (2012) Targeting myocardial substrate metabolism in heart failure: Potential for new therapies. Eur J Heart Fail 14:120-129. doi:10.1093/eurjhf/hfr173
9. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M (2005) Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38:367-374. doi:10.1016/j.yjmcc. 2004.12.001
10. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-662. doi:10.1038/nature03434
11. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483-495. doi:10.1016/j.cell.2005.02.001
12. Bao J, Lu Z, Joseph JJ, Carabenciov D, Dimond CC, Pang L, Samsel L, McCoy JP Jr, Leclerc J, Nguyen P, Gius D, Sack MN (2010) Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J Cell Biochem 110:238-247. doi:10.1002/jcb.22531
13. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342. doi:10.1038/ nature05354
14. Beauloye C, Bertrand L, Horman S, Hue L (2011) AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 90:224-233. doi: 10.1093/cvr/cvr034
15. Belke DD, Swanson EA, Dillmann WH (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53:3201-3208
16. Bersin RM, Stacpoole PW (1997) Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J 134:841-855. doi:S0002870397001440
17. Bhashyam S, Fields AV, Patterson B, Testani JM, Chen L, Shen YT, Shannon RP (2010) Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy. Circ Heart Fail 3:512-521. doi: 10.1161/CIRCHEARTFAILURE.109.900282
18. Bodyak N, Rigor DL, Chen YS, Han Y, Bisping E, Pu WT, Kang PM (2007) Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 293:H829-H835. doi:10.1152/ajpheart.01409.2006
19. Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cardiovasc Res 83:247-261. doi:10.1093/cvr/ cvp033
20. Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, Easlon EJ, Lin SJ, Guarente L (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4:e31. doi:10.1371/journal.pbio.0040031
21. Brooks CL, Gu W (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2:456-462. doi: 10.1007/s13238-011-1063-9
22. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J (2009) AMPK regulates energy expenditure by modulating NAD? metabolism and SIRT1 activity. Nature 458:1056-1060. doi:10.1038/nature 07813
23. Chen CH, Sun L, Mochly-Rosen D (2010) Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res 88:51-57. doi:10.1093/cvr/cvq192
24. Chen R, Dioum EM, Hogg RT, Gerard RD, Garcia JA (2011) Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J Biol Chem 286:13869-13878. doi: 10.1074/jbc.M110.175414
25. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100:10794-10799. doi: 10.1073/pnas.1934713100
26. Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA (2002) Defective intracellular Ca(2?) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283:H1398-H1408. doi:10.1152/ajpheart.00313.2002
27. Clarke SJ, McStay GP, Halestrap AP (2002) Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 277:34793-34799. doi:10.1074/jbc.M202191200
28. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM, Sinclair DA (2004) Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13:627-638
29. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392. doi: 10.1126/science.1099196
30. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325:201-204. doi:10.1126/science.1173635
31. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993-1002. doi:10.1016/j. neuroscience.2009.01.017
32. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA (2009) Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324:1289-1293. doi:10.1126/science.1169956
33. Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A, Maulik N (2006) Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44:43-49. doi:10.1385/CBB:44:1:043
34. Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, Geny B, Mettauer B, Veksler V, Ventura-Clapier R (2009) Control by circulating factors of mitochondrial function and transcription cascade in heart failure: A role for endothelin-1 and angiotensin II. Circ Heart Fail 2:342-350. doi:10.1161/ CIRCHEART FAILURE.108.812099
35. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1a. EMBO J 26:1913-1923. doi: 10.1038/sj.emboj.7601633
36. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500-508. doi:10.1172/JCI24408
37. Gottlieb RA, Finley KD, Mentzer RM Jr (2009) Cardioprotection requires taking out the trash. Basic Res Cardiol 104:169-180. doi:10.1007/s00395-009- 0011-9
38. Guarente L (2011) Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 364:2235-2244. doi:10.1056/ NEJMra1100831
39. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70-76
40. Gwathmey JK, Yerevanian AI, Hajjar RJ (2011) Cardiac gene therapy with SERCA2a: From bench to bedside. J Mol Cell Cardiol 50:803-812. doi:10.1016/j.yjmcc.2010.11.011
41. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA (2010) Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2:914-923
42. Hallows WC, Lee S, Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 103:10230-10235. doi:10.1073/pnas.0604392103
43. Hamacher-Brady A, Brady NR, Gottlieb RA (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281:29776-29787. doi:10.1074/ jbc.M603783200
44. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA, Gottlieb RA, Gustafsson AB (2007) Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14:146-157. doi:10.1038/sj.cdd. 4401936
45. Hariharan N, Maejima Y, Nakae J, Paik J, Depinho RA, Sadoshima J (2010) Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res 107:1470-1482. doi:10.1161/CIRCRESAHA. 110.227371
46. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ (2000) Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49:527-531
47. Heather LC, Cole MA, Tan JJ, Ambrose LJ, Pope S, Abd-Jamil AH, Carter EE, Dodd MS, Yeoh KK, Schofield CJ, Clarke K (2012) Metabolic adaptation to chronic hypoxia in cardiac mitochondria. Basic Res Cardiol 107:268. doi:10.1007/s00395-012-0268-2
48. Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: The Holy Grail of cardioprotection. Basic Res Cardiol 105:151-154. doi: 10.1007/s00395-009-0080-9
49. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121-125. doi:10.1038/nature 08778
50. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, Shimohama S, Sato M, Horio Y (2008) Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci USA 105:15599-15604. doi:10.1073/ pnas.0800612105
51. Hock MB, Kralli A (2009) Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 71:177-203. doi:10.1146/annurev. physiol.010908.163119
52. HuaY,Zhang Y, Ceylan-IsikAF,WoldLE,Nunn JM, Ren J (2011) Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: Role of autophagy. Basic Res Cardiol 106:1173-1191. doi:10.1007/s00395-011-0222-8
53. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P, Tartaglia LA, Garlid KD (1999) Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274:26003-26007
54. Kawashima T, Inuzuka Y, Okuda J, Kato T, Niizuma S, Tamaki Y, Iwanaga Y, Kawamoto A, Narazaki M, Matsuda T, Adachi S, Takemura G, Kita T, Kimura T, Shioi T (2011) Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice. J Mol Cell Cardiol 51:1026-1036. doi: 10.1016/j.yjmcc.2011.09.013
55. Kendrick AA, Choudhury M, Rahman SM, McCurdy CE, Friederich M, Van Hove JL, Watson PA, Birdsey N, Bao J, Gius D, Sack MN, Jing E, Kahn CR, Friedman JE, Jonscher KR (2011) Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J 433:505-514. doi: 10.1042/bj20100791
56. Kim I, Rodriguez-Enriquez S, Lemasters JJ (2007) Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462:245-253. doi:10.1016/j.abb.2007.03.034
57. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23:607-618. doi: 10.1016/j.molcel.2006.06.026
58. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, Hayakawa Y, Zimmermann R, Bauer E, Klovekorn WP, Schaper J (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92:715-724. doi:10.1161/01.RES. 0000067471.95890.5C
59. Kupriyanov VV, Lakomkin VL, Kapelko VI, Steinschneider A, Ruuge EK, Saks VA (1987) Dissociation of adenosine triphosphate levels and contractile function in isovolumic hearts perfused with 2-deoxyglucose. J Mol Cell Cardiol 19:729-740
60. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127:1109-1122. doi: 10.1016/j.cell.2006.11.013
61. Lan F, Cacicedo JM, Ruderman N, Ido Y (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283:27628-27635. doi:10.1074/jbc. M805711200
62. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T (2008) A role for the NADdependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 105:3374-3379. doi:10.1073/pnas. 0712145105
63. Lee L, Campbell R, Scheuermann-Freestone M, Taylor R, Gunaruwan P, Williams L, Ashrafian H, Horowitz J, Fraser AG, Clarke K, Frenneaux M (2005) Metabolic modulation with perhexiline in chronic heart failure: A randomized, controlled trial of short-term use of a novel treatment. Circulation 112:3280-3288. doi:10.1161/CIRCULATIONAHA.105.551457
64. Li L, Muhlfeld C, Niemann B, Pan R, Li R, Hilfiker-Kleiner D, Chen Y, Rohrbach S (2011) Mitochondrial biogenesis and PGC-1a deacetylation by chronic treadmill exercise: Differential response in cardiac and skeletal muscle. Basic Res Cardiol 106:1221-1234. doi:10.1007/s00395-011-0213-9
65. Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ (2010) p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS ONE 5:e10486. doi: 10.1371/journal.pone.0010486
66. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376-381. doi:10.1038/ng1295-376
67. Limas CJ, Olivari MT, Goldenberg IF, Levine TB, Benditt DG, Simon A (1987) Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 21:601-605
68. Loch T, Vakhrusheva O, Piotrowska I, Ziolkowski W, Ebelt H, Braun T, Bober E (2009) Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res 82:448-457. doi:10.1093/cvr/cvp092
69. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV Jr, Weissman S, Verdin E, Schwer B (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27:8807-8814. doi:10.1128/MCB.01636-07
70. Lopaschuk GD, Wall SR, Olley PM, Davies NJ (1988) Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 63:1036-1043
71. Lorenzen JM, Martino F, Thum T (2012) Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 107:245. doi: 10.1007/s00395-012-0245- 9
72. Lu Z, Bourdi M, Li JH, Aponte AM, Chen Y, Lombard DB, Gucek M, Pohl LR, Sack MN (2011) SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep 12:840-846. doi:10.1038/embor.2011.121
73. Lu Z, Scott I, Webster BR, Sack MN (2009) The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology. Circ Res 105:830-841. doi:10.1161/CIRCRESAHA.109. 204974
74. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2a promotes cell survival under stress. Cell 107:137-148
75. Maciel LM, Polikar R, Rohrer D, Popovich BK, Dillmann WH (1990) Age-induced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca2(?)-ATPase of the rat heart. Circ Res 67:230-234
76. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Selfeating and self-killing: Crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741-752. doi:10.1038/nrm2239
77. Marin-Garcia J, Goldenthal MJ (2008) Mitochondrial centrality in heart failure. Heart Fail Rev 13:137-150. doi:10.1007/ s10741-007-9079-1
78. Michan S, Sinclair D (2007) Sirtuins in mammals: Insights into their biological function. Biochem J 404:1-13. doi:10.1042/ BJ20070140
79. Miura T, Tanno M (2012) The mPTP and its regulatory proteins: Final common targets of signalling pathways for protection against necrosis. Cardiovasc Res 94:181-189. doi:10.1093/cvr/ cvr302
80. Mizushima N (2007) Autophagy: Process and function. Genes Dev 21:2861-2873. doi:10.1101/gad.1599207
81. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652-658. doi:10.1038/nature03317
82. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N, Otsu K (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13:619-624. doi:10.1038/nm1574
83. Nasrin N, Kaushik VK, Fortier E, Wall D, Pearson KJ, de Cabo R, Bordone L (2009) JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS ONE 4:e8414. doi:10.1371/ journal.pone.0008414
84. Nemoto S, Fergusson MM, Finkel T (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1a. J Biol Chem 280:16456-16460. doi:10.1074/jbc. M501485200
85. Neubauer S (2007) The failing heart-an engine out of fuel. N Engl J Med 356:1140-1151. doi:10.1056/NEJMra063052
86. Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP (2004) Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 110:955-961. doi:10.1161/01.CIR.0000139339. 85840.DD
87. Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y, Kobayashi H, Shimamoto K (2004) Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 61:610-619. doi:10.1016/j.cardiores.2003. 10.022
88. Oka S, Alcendor R, Zhai P, Park JY, Shao D, Cho J, Yamamoto T, Tian B, Sadoshima J (2011) PPARa-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab 14:598-611. doi: 10.1016/j.cmet.2011.10.001
89. Pfister JA, Ma C, Morrison BE, D'Mello SR (2008) Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 3:e4090. doi:10.1371/journal.pone.0004090
90. Pillai JB, Isbatan A, Imai S, Gupta MP (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD? depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280:43121-43130. doi:10.1074/jbc.M506162200
91. Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP (2010) Mitochondrial SIRT3 and heart disease. Cardiovasc Res. doi: 10.1093/cvr/cvq250
92. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133-3144. doi:10.1074/jbc.M109.077271
93. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473-481. doi: 10.1056/NEJMoa071142
94. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM, Dimmeler S (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21:2644-2658. doi:10.1101/gad.435107
95. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662-667. doi:10.1016/j.cmet. 2010.11.015
96. Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, Veksler V, Garnier A, Ventura-Clapier R (2011) Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE 6:e26391. doi: 10.1371/journal.pone.0026391
97. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 434:113-118. doi:10.1038/nature03354
98. Sakamoto J, Miura T, Shimamoto K, Horio Y (2004) Predominant expression of Sir2a, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett 556:281-286
99. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444-448. doi: 10.1038/nature05602
100. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S (2003) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5:320-329. doi:10.1038/ ncb950
101. Scher MB, Vaquero A, Reinberg D (2007) SirT3 is a nuclear NAD?-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21:920-928. doi: 10.1101/gad.1527307
102. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382:790-801. doi:10.1016/j.jmb.2008.07.048
103. Schmidt-Schweda S, Holubarsch C (2000) First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin Sci (Lond) 99:27-35
104. Selby PL, Sherratt HS (1989) Substituted 2-oxiranecarboxylic acids: A new group of candidate hypoglycaemic drugs. Trends Pharmacol Sci 10:495-500
105. Shin SM, Cho IJ, Kim SG (2009) Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3b inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol Pharmacol 76:884-895. doi:10.1124/mol.109.058479
106. Shinmura K, Tamaki K, Bolli R (2008) Impact of 6-mo caloric restriction on myocardial ischemic tolerance: Possible involvement of nitric oxide-dependent increase in nuclear Sirt1. Am J Physiol Heart Circ Physiol 295:H2348-H2355. doi:10.1152/ ajpheart.00602.2008
107. Shinmura K, Tamaki K, Sano M, Nakashima-Kamimura N, Wolf AM, Amo T, Ohta S, Katsumata Y, Fukuda K, Ishiwata K, Suematsu M, Adachi T (2011) Caloric restriction primes mitochondria for ischemic stress by deacetylating specific mitochondrial proteins of the electron transport chain. Circ Res 109:396-406. doi:10.1161/CIRCRESAHA.111.243097
108. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108-2118. doi:10.1172/ JCI24682
109. Shulga N, Wilson-Smith R, Pastorino JG (2010) Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci 123:894-902. doi: 10.1242/jcs.061846
110. Smith J (2002) Human Sir2 and the 'silencing' of p53 activity. Trends Cell Biol 12:404-406
111. Starling RC, Hammer DF, Altschuld RA (1998) Human myocardial ATP content and in vivo contractile function. Mol Cell Biochem 180:171-177
112. Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M (2010) Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 298:H833-H843. doi:10.1152/ajpheart.00418.2009
113. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307-319. doi: 10.1016/j.cmet.2007.08.014
114. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119:2758-2771. doi:10.1172/ JCI39162
115. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28:6384-6401. doi: 10.1128/MCB.00426-08
116. Tanner KG, Landry J, Sternglanz R, Denu JM (2000) Silent information regulator 2 family of NAD-dependent histone/ protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 97:14178-14182. doi: 10.1073/pnas.250422697
117. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, Horio Y (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375-8382. doi:10.1074/jbc.M109.090266
118. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD?-dependent histone deacetylase SIRT1. J Biol Chem 282:6823-6832. doi: 10.1074/jbc.M609554200
119. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D (2010) Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 40:893-904. doi:10.1016/j.molcel. 2010.12.013
120. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, Hirota H (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25:9554-9575. doi:10.1128/MCB.25.21.9554-9575.2005
121. Turdi S, Fan X, Li J, Zhao J, Huff AF, Du M, Ren J (2010) AMP-activated protein kinase deficiency exacerbates aginginduced myocardial contractile dysfunction. Aging Cell 9:592-606. doi:10.1111/j.1474-9726.2010.00586.x
122. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R (2008) Mechanisms underlying caloric restriction and lifespan regulation: Implications for vascular aging. Circ Res 102:519-528. doi:10.1161/CIRCRESAHA.107.168369
123. Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, Fraquelli M, Vergani A, Gianni C, Carmagnola L, Fargion S (2004) The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet 41:946-950. doi:10.1136/jmg. 2004.019588
124. van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM (2004) FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 279:28873-28879. doi:10.1074/jbc. M401138200
125. Venkatapuram S, Wang C, Krolikowski JG, Weihrauch D, Kersten JR, Warltier DC, Pratt PF Jr, Pagel PS (2006) Inhibition of apoptotic protein p53 lowers the threshold of isofluraneinduced cardioprotection during early reperfusion in rabbits. Anesth Analg 103:1400-1405. doi:10.1213/01.ane.0000240903. 63832.d8e
126. Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: The central role of PGC-1a. Cardiovasc Res 79:208-217. doi:10.1093/cvr/cvn098
127. Wakabayashi T (2002) Megamitochondria formation-physiology and pathology. J Cell Mol Med 6:497-538
128. Witteles RM, Fowler MB (2008) Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 51:93-102. doi:10.1016/j.jacc.2007.10.021
129. Zorov DB, Juhaszova M, Yaniv Y, Nuss HB, Wang S, Sollott SJ (2009) Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 83:213-225. doi: 10.1093/cvr/cvp151